HRMY
Harmony Biosciences Holdings
NASDAQ · Pharmaceuticals
$37.27
+0.86 (+2.36%)
Performance
1D
—
1W
-1.51%
1M
-2.61%
3M
+13.01%
6M
+1.64%
1Y
-1.90%
YTD
-0.29%
Open$36.74
Previous Close$36.41
Day High$37.54
Day Low$36.17
52W High$40.87
52W Low$25.52
Volume516.7K
Avg Volume510.3K
Market Cap2.15B
P/E Ratio11.56
EPS$3.18
SectorPharmaceuticals
Volume Analysis
1.01x average volume
Technical Indicators
SMA 50
$37.48
Below
SMA 200
$33.94
Above
RSI (14)
57.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+150.9% upside
Current
$37.27
$37.27
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 711.36M | 535.78M | 495.90M |
| Net Income | 144.80M | 98.16M | 96.19M |
| Profit Margin | 20.4% | 19.3% | 19.4% |
| EBITDA | 213.59M | 152.83M | 152.11M |
| Free Cash Flow | — | — | 107.84M |
| Rev Growth | +32.8% | +32.8% | +9.0% |
| Debt/Equity | 0.27 | 0.27 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |